Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > EBITDA Margin

Bristol-Myers Squibb Company EBITDA Margin Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Bristol-Myers Squibb Company EBITDA Margin for the quarter ending September 09, 2020 was $44m a 26.12% increase of 12m year over year
  • Bristol-Myers Squibb Company EBITDA Margin for the last 12 months ending September 09, 2020 was $43m a 21.69% increase of 9m year over year
  • Bristol-Myers Squibb Company Annual EBITDA Margin for 2019 was $33m a 7.12% increase of 2m from 2018
  • Bristol-Myers Squibb Company Annual EBITDA Margin for 2018 was $31m a 29.26% increase of 9m from 2017
  • Bristol-Myers Squibb Company Annual EBITDA Margin for 2017 was $22m a -33.80% decrease of -7m from 2016
Other Margins & Efficiency Metrics:
  • Bristol-Myers Squibb Company Return on Capital % for the quarter ending December 12, 2018 was 20.85 a 12.59% increase of 2.62 year over year
  • Bristol-Myers Squibb Company Return on Equity % for the quarter ending December 12, 2018 was 34.62 a -39.57% decrease of -13.70 year over year
View Chart On Koyfin

Quarterly BMY EBITDA Margin Data

09/2020$44m
06/2020$46m
03/2020$44m
12/2019$33m
09/2019$33m
06/2019$36m
03/2019$33m
12/2018$28m
09/2018$33m
06/2018$32m

Annual BMY EBITDA Margin Data

2019$33m
2018$31m
2017$22m
2016$29m
2015$27m
2014$26m
2013$26m
2012$30m
2011$37m
2010$36m